• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎的新科学和治疗模式。

New science and treatment paradigms for atopic dermatitis.

机构信息

Department of Surgery (Section of Dermatology), Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; Department of Dermatology, University of Connecticut School of Medicine, Framingham, Connecticut, USA.

出版信息

Curr Opin Pediatr. 2018 Feb;30(1):161-168. doi: 10.1097/MOP.0000000000000560.

DOI:10.1097/MOP.0000000000000560
PMID:29176352
Abstract

PURPOSE OF THE REVIEW

The prevalence of atopic dermatitis is increasing in industrialized countries for unclear reasons. One theory centers on reduced exposure to microbes during infancy and childhood. Alterations in the epidermal permeability barrier, place certain patients at risk for the immunological dysfunction seen in atopic dermatitis. This review examines current research pertaining to the epidermal permeability barrier, the cutaneous microbiome, and the immunology of atopic dermatitis. New collaborative research has led to evidence-based management guidelines.

RECENT FINDINGS

Increased skin barrier permeability and dysfunction of innate and adaptive immunity cause atopic dermatitis. Genetic and environmental factors leading to decreased filaggrin underlie many cases of atopic dermatitis. Defective epidermal barrier function allows for an increased density of Staphylococcus aureus and a subsequent shift in adaptive immunity to a type 2 immune response. Multiple evaluation and management guidelines have been published based on current available evidence. These guidelines highlight state of the art management of seven main areas: inflammation, infection, irritation, itch, ichthyosis (dry skin), immunological influences, and impeding (comorbid) conditions.

SUMMARY

Pediatricians are central to the successful diagnosis and management of atopic dermatitis. Increased basic and clinical research and well published clinical guidelines will lead to improved outcomes for the patients and families affected by this chronic relapsing disorder.

摘要

目的综述

由于不明原因,特应性皮炎在工业化国家的发病率正在上升。有一种理论认为,这与婴儿和儿童时期接触微生物减少有关。表皮渗透性屏障的改变使某些患者易患特应性皮炎的免疫功能障碍。本综述检查了有关表皮渗透性屏障、皮肤微生物组和特应性皮炎免疫学的当前研究。新的合作研究为循证管理指南提供了依据。

最近的发现

增加的皮肤屏障通透性和先天及适应性免疫功能障碍导致特应性皮炎。导致丝聚蛋白减少的遗传和环境因素是许多特应性皮炎的基础。表皮屏障功能缺陷可导致金黄色葡萄球菌密度增加,并随后导致适应性免疫向 2 型免疫反应转变。基于当前可用证据,已经发布了多个评估和管理指南。这些指南强调了七个主要领域的最新管理方法:炎症、感染、刺激、瘙痒、鱼鳞病(皮肤干燥)、免疫影响和阻碍(合并)条件。

总结

儿科医生是成功诊断和管理特应性皮炎的核心。增加基础和临床研究以及出版良好的临床指南将改善受这种慢性复发性疾病影响的患者和家庭的治疗效果。

相似文献

1
New science and treatment paradigms for atopic dermatitis.特应性皮炎的新科学和治疗模式。
Curr Opin Pediatr. 2018 Feb;30(1):161-168. doi: 10.1097/MOP.0000000000000560.
2
Microbiome and pediatric atopic dermatitis.微生物群与儿童特应性皮炎
J Dermatol. 2015 Dec;42(12):1137-42. doi: 10.1111/1346-8138.13072. Epub 2015 Sep 21.
3
The ins and outs of an 'outside-in' view of allergies: atopic dermatitis and allergy prevention.过敏的“由外而内”观点面面观:特应性皮炎与过敏预防。
Curr Opin Pediatr. 2018 Aug;30(4):576-581. doi: 10.1097/MOP.0000000000000646.
4
The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.天然免疫信号在特应性皮炎发病机制中的作用及对治疗的影响。
Semin Immunopathol. 2016 Jan;38(1):29-43. doi: 10.1007/s00281-015-0544-y. Epub 2015 Nov 16.
5
Sweat mechanisms and dysfunctions in atopic dermatitis.特应性皮炎的出汗机制和功能障碍。
J Dermatol Sci. 2018 Feb;89(2):105-111. doi: 10.1016/j.jdermsci.2017.11.005. Epub 2017 Nov 21.
6
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.特应性皮炎发病机制中的皮肤屏障异常。
Curr Opin Allergy Clin Immunol. 2009 Oct;9(5):437-46. doi: 10.1097/ACI.0b013e32832e7d36.
7
Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation.特应性皮炎的上皮屏障功能障碍:一个连接微生物组改变和免疫失调的皮肤-肠道-肺模型。
Br J Dermatol. 2018 Sep;179(3):570-581. doi: 10.1111/bjd.16734. Epub 2018 Jul 11.
8
Atopic dermatitis and skin allergies - update and outlook.特应性皮炎和皮肤过敏——更新与展望。
Allergy. 2013 Dec;68(12):1509-19. doi: 10.1111/all.12324. Epub 2013 Nov 26.
9
An Update on the Pathophysiology of Atopic Dermatitis.特应性皮炎病理生理学的最新进展
Dermatol Clin. 2017 Jul;35(3):317-326. doi: 10.1016/j.det.2017.02.006. Epub 2017 May 6.
10
Atopic Dermatitis: Update for Pediatricians.特应性皮炎:给儿科医生的最新资讯
Pediatr Ann. 2016 Aug 1;45(8):e280-6. doi: 10.3928/19382359-20160720-05.

引用本文的文献

1
The Impact of Immune Cells, Metabolites, Inflammatory Factors, and Circulating Proteins on Atopic Dermatitis: Insights from a Mendelian Randomization Study.免疫细胞、代谢产物、炎症因子和循环蛋白对特应性皮炎的影响:孟德尔随机化研究的见解
Clin Cosmet Investig Dermatol. 2024 Dec 21;17:2999-3011. doi: 10.2147/CCID.S495217. eCollection 2024.
2
Serum Vitamin D Level and Efficacy of Vitamin D Supplementation in Children with Atopic Dermatitis: A Systematic Review and Meta-analysis.血清维生素 D 水平与维生素 D 补充对特应性皮炎患儿疗效的系统评价和荟萃分析。
Comput Math Methods Med. 2022 Jul 20;2022:9407888. doi: 10.1155/2022/9407888. eCollection 2022.
3
The role of gut microbiome in inflammatory skin disorders: A systematic review.
肠道微生物群在炎症性皮肤病中的作用:一项系统评价。
Dermatol Reports. 2021 Dec 28;14(1):9188. doi: 10.4081/dr.2022.9188. eCollection 2022 Mar 11.
4
Dual Delivery of Fluticasone Propionate and Levocetirizine Dihydrochloride for the Management of Atopic Dermatitis Using a Microemulsion-Based Topical Gel.使用基于微乳的外用凝胶双递送丙酸氟替卡松和盐酸左西替利嗪治疗特应性皮炎
ACS Omega. 2022 Feb 28;7(9):7696-7705. doi: 10.1021/acsomega.1c06393. eCollection 2022 Mar 8.
5
Safety and efficacy of hydroxytyrosol-based formulation on skin inflammation: in vitro evaluation on reconstructed human epidermis model.基于羟基酪醇的配方对皮肤炎症的安全性和疗效:在重建人体表皮模型上的体外评价。
Daru. 2019 Jun;27(1):283-293. doi: 10.1007/s40199-019-00274-3. Epub 2019 May 26.
6
Treatment of Atopic Dermatitis with Biologic Drugs.生物药物治疗特应性皮炎
Dermatol Ther (Heidelb). 2018 Dec;8(4):527-538. doi: 10.1007/s13555-018-0258-x. Epub 2018 Sep 4.